05.09.2022 • NewsClariantGlobal AminesQuats

Clariant Sells Quats to Global Amines

Clariant has agreed to sell its quats business to Singapore’s Global Amines for $113 million. Global Amines is a 50:50 joint venture between Clariant and Singapore-based agricultural and oleochemicals company Wilmar.

The deal will be an asset sale of the sites in Germany, Indonesia and Brazil and will provide for tolling agreements where necessary.

Quats – or quaternary ammonium compounds – are a group of chemicals used for various purposes, including as preservatives, surfactants and antistatic agents. The sale includes products sold under the Praepagen and Genamin trademarks that Clariant said have a well-established presence in the home and personal care market.

“The quats and esterquats business is an ideal fit for Global Amines Company as it perfectly complements our product portfolio and our ability to offer customers the best and most competitive solutions from a complete range of amines, quats, amines derivatives and betaines,” said Ernesto Horikoshi, group general manager of Global Amines.

He added: “The acquisition plays to the JV’s strategic strengths by building on Clariant’s long-standing experience in specialties chemicals and Wilmar’s position as Asia’ leading agribusiness and on its global oleochemicals business. This will guarantee a solid business continuity on a competitive and attractive basis for an ever-stronger future growth.”

The transaction, which remains subject to regulatory approvals and the usual closing conditions, is expected to complete in the first half of 2023.

Clariant said the divestment is a further step in its transformation to focus its operations purely on specialty chemicals.

Author: Elaine Burridge, Freelance Author

© Clariant
© Clariant

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.